• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超分子调控肿瘤微环境 pH 值触发药物作用增强纳米医学治疗脑胶质瘤的疗效。

Supramolecularly enabled pH- triggered drug action at tumor microenvironment potentiates nanomedicine efficacy against glioblastoma.

机构信息

Innovation Center of NanoMedicine, Kawasaki Institute of Industrial Promotion, 3-25-14 Tonomachi, Kawasaki-ku, Kawasaki, 212-0821, Japan.

Innovation Center of NanoMedicine, Kawasaki Institute of Industrial Promotion, 3-25-14 Tonomachi, Kawasaki-ku, Kawasaki, 212-0821, Japan.

出版信息

Biomaterials. 2021 Jan;267:120463. doi: 10.1016/j.biomaterials.2020.120463. Epub 2020 Oct 23.

DOI:10.1016/j.biomaterials.2020.120463
PMID:33130321
Abstract

The crucial balance of stability in blood-circulation and tumor-specific delivery has been suggested as one of the challenges for effective bench-to-bedside translation of nanomedicines (NMs). Herein, we developed a supramolecularly enabled tumor-extracellular (T) pH-triggered NM that can maintain the micellar structure with the entrapped-drug during systemic circulation and progressively release drug in the tumor by rightly sensing heterogeneous tumor-pH. Desacetylvinblastine hydrazide (DAVBNH), a derivative of potent anticancer drug vinblastine, was conjugated to an aliphatic ketone-functionalized poly(ethylene glycol)-b-poly(amino acid) copolymer and the hydrolytic stability of the derived hydrazone bond was efficiently tailored by exploiting the compartmentalized structure of polymer micelle. We confirmed an effective and safe therapeutic application of T pH-sensitive DAVBNH-loaded micelle (T-micelle) in orthotopic glioblastoma (GBM) models, extending median survival to 1.4 times in GBM xenograft and 2.6 times in GBM syngeneic model, compared to that of the free DAVBNH. The work presented here offers novel chemical insights into the molecular design of smart NMs correctly sensing T-pH via programmed functionalities. The practical engineering strategy based on a clinically relevant NM platform, and the encouraging therapeutic application of T-micelle in GBM, one of the most lethal human cancers, thus suggests the potential clinical translation of this system against other types of common cancers, including GBM.

摘要

在纳米医学(NM)从实验室向临床转化的过程中,如何实现血液循环稳定性和肿瘤靶向输送之间的平衡一直是一个巨大的挑战。本文构建了一种基于超分子组装的肿瘤细胞外(T)pH 响应型 NM,该纳米载体在血液循环中能够保持药物包载的胶束结构,并通过正确感知肿瘤的异质性 pH 实现药物的持续释放。我们将具有强抗癌活性的长春碱衍生物去乙酰长春碱腙(DAVBNH)偶联到脂肪族酮功能化的聚乙二醇-聚氨基酸共聚物上,利用聚合物胶束的分隔结构有效调控了腙键的水解稳定性。我们在原位胶质母细胞瘤(GBM)模型中证实了 T pH 敏感型 DAVBNH 载药胶束(T-胶束)具有有效的治疗效果和安全性,与游离 DAVBNH 相比,其在 GBM 异种移植和 GBM 同基因模型中的中位生存期分别延长了 1.4 倍和 2.6 倍。本研究为通过程序功能正确感知 T-pH 的智能 NM 的分子设计提供了新的化学见解。该工作基于一种临床相关 NM 平台的实用工程策略,以及 T-胶束在 GBM 中的令人鼓舞的治疗应用,提示该系统具有针对其他常见癌症(包括 GBM)进行临床转化的潜力。

相似文献

1
Supramolecularly enabled pH- triggered drug action at tumor microenvironment potentiates nanomedicine efficacy against glioblastoma.超分子调控肿瘤微环境 pH 值触发药物作用增强纳米医学治疗脑胶质瘤的疗效。
Biomaterials. 2021 Jan;267:120463. doi: 10.1016/j.biomaterials.2020.120463. Epub 2020 Oct 23.
2
Verteporfin-Loaded Anisotropic Poly(Beta-Amino Ester)-Based Micelles Demonstrate Brain Cancer-Selective Cytotoxicity and Enhanced Pharmacokinetics.载有维替泊芬的各向异性聚(β-氨基酸酯)基胶束具有脑肿瘤选择性细胞毒性和增强的药代动力学。
Int J Nanomedicine. 2019 Dec 23;14:10047-10060. doi: 10.2147/IJN.S231167. eCollection 2019.
3
Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(ε-caprolactone) micelles.通过环状RGD肽功能化的可逆核心交联多功能聚乙二醇-b-聚己内酯胶束进行靶向胶质瘤化疗。
Acta Biomater. 2017 Mar 1;50:396-406. doi: 10.1016/j.actbio.2017.01.007. Epub 2017 Jan 5.
4
PEG-Detachable Polymeric Micelles Self-Assembled from Amphiphilic Copolymers for Tumor-Acidity-Triggered Drug Delivery and Controlled Release.聚乙二醇修饰的两亲性嵌段共聚物聚合物胶束用于肿瘤酸性触发的药物递送和控制释放
ACS Appl Mater Interfaces. 2019 Feb 13;11(6):5701-5713. doi: 10.1021/acsami.8b13059. Epub 2019 Jan 29.
5
Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.聚乙二醇外壳可脱落的 TAT 修饰的核交联纳米胶束:TAT 增强的细胞摄取和溶酶体 pH 触发的阿霉素释放。
Colloids Surf B Biointerfaces. 2020 Apr;188:110772. doi: 10.1016/j.colsurfb.2020.110772. Epub 2020 Jan 20.
6
pH-sensitive micelles self-assembled from polymer brush (PAE--cholesterol)--PEG--(PAE--cholesterol) for anticancer drug delivery and controlled release.由聚合物刷(PAE-胆固醇)-聚乙二醇-(PAE-胆固醇)自组装而成的pH敏感胶束用于抗癌药物递送与控释。
Int J Nanomedicine. 2017 Mar 21;12:2215-2226. doi: 10.2147/IJN.S130037. eCollection 2017.
7
Bloodstream Stability Predetermines the Antitumor Efficacy of Micellar Polymer-Doxorubicin Drug Conjugates with pH-Triggered Drug Release.血流稳定性决定了具有 pH 触发药物释放的胶束聚合物-阿霉素药物偶联物的抗肿瘤疗效。
Mol Pharm. 2018 Sep 4;15(9):3654-3663. doi: 10.1021/acs.molpharmaceut.8b00156. Epub 2018 Mar 21.
8
Cation-Free siRNA Micelles as Effective Drug Delivery Platform and Potent RNAi Nanomedicines for Glioblastoma Therapy.无阳离子 siRNA 胶束作为有效的药物传递平台和有效的胶质母细胞瘤治疗 RNAi 纳米药物。
Adv Mater. 2021 Nov;33(45):e2104779. doi: 10.1002/adma.202104779. Epub 2021 Sep 18.
9
Dual Stable Nanomedicines Prepared by Cisplatin-Crosslinked Camptothecin Prodrug Micelles for Effective Drug Delivery.顺铂交联喜树碱前药胶束构建的双稳定纳米药物用于有效的药物递送
ACS Appl Mater Interfaces. 2019 Jun 12;11(23):20649-20659. doi: 10.1021/acsami.9b03960. Epub 2019 May 31.
10
Polymeric micelles with citraconic amide as pH-sensitive bond in backbone for anticancer drug delivery.主链中含柠康酰胺作为pH敏感键的聚合物胶束用于抗癌药物递送
Int J Pharm. 2014 Aug 25;471(1-2):28-36. doi: 10.1016/j.ijpharm.2014.05.010. Epub 2014 May 13.

引用本文的文献

1
A pH-responsive PEG coating strategy for enhancing the enrichment of small extracellular vesicles towards disease regions with acidic microenvironment.一种用于增强小细胞外囊泡向具有酸性微环境的疾病区域富集的pH响应性聚乙二醇包被策略。
Mater Today Bio. 2025 May 17;32:101878. doi: 10.1016/j.mtbio.2025.101878. eCollection 2025 Jun.
2
Supramolecular nanomedicine in the intelligent cancer therapy: recent advances and future.智能癌症治疗中的超分子纳米医学:最新进展与未来展望
Front Pharmacol. 2024 Oct 11;15:1490139. doi: 10.3389/fphar.2024.1490139. eCollection 2024.
3
Highly sensitive plasmonic paper substrate fabricated via amphiphilic polymer self-assembly in microdroplet for detection of emerging pharmaceutical pollutants.
通过两亲性聚合物在微滴中自组装制备的用于检测新型药物污染物的高灵敏度等离子体纸质基底
Nano Converg. 2024 Mar 29;11(1):13. doi: 10.1186/s40580-024-00420-x.
4
Drug resistance in glioblastoma: from chemo- to immunotherapy.胶质母细胞瘤中的耐药性:从化疗到免疫治疗
Cancer Drug Resist. 2023 Oct 11;6(4):688-708. doi: 10.20517/cdr.2023.82. eCollection 2023.
5
Tuning the Cross-Linking Density and Cross-Linker in Core Cross-Linked Polymeric Micelles and Its Effects on the Particle Stability in Human Blood Plasma and Mice.调整核交联聚合物胶束中的交联密度和交联剂及其对人血浆和小鼠中颗粒稳定性的影响。
Biomacromolecules. 2023 Aug 14;24(8):3545-3556. doi: 10.1021/acs.biomac.3c00308. Epub 2023 Jul 14.
6
A Targeted and pH-Responsive Nano-Graphene Oxide Nanoparticle Loaded with Doxorubicin for Synergetic Chemo-Photothermal Therapy of Oral Squamous Cell Carcinoma.载阿霉素的靶向 pH 响应性纳米氧化石墨烯用于口腔鳞状细胞癌协同化疗-光热治疗。
Int J Nanomedicine. 2023 Jun 17;18:3309-3324. doi: 10.2147/IJN.S402249. eCollection 2023.
7
Efficient Synergistic Antibacterial Activity of α-MSH Using Chitosan-Based Versatile Nanoconjugates.使用基于壳聚糖的多功能纳米共轭物实现α-促黑素细胞激素的高效协同抗菌活性。
ACS Omega. 2023 Mar 30;8(14):12865-12877. doi: 10.1021/acsomega.2c08209. eCollection 2023 Apr 11.
8
Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM).多形性胶质母细胞瘤(GBM)的耐药机制及当前治疗选择
Cancers (Basel). 2023 Apr 1;15(7):2116. doi: 10.3390/cancers15072116.
9
Bioresponsive Polymers for Nanomedicine-Expectations and Reality!用于纳米医学的生物响应性聚合物——期望与现实!
Polymers (Basel). 2022 Sep 3;14(17):3659. doi: 10.3390/polym14173659.
10
Stimuli Responsive Nitric Oxide-Based Nanomedicine for Synergistic Therapy.用于协同治疗的刺激响应型一氧化氮基纳米药物
Pharmaceutics. 2021 Nov 12;13(11):1917. doi: 10.3390/pharmaceutics13111917.